Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001453687-16-000020
Filing Date
2016-12-14
Accepted
2016-12-14 16:29:39
Documents
11
Period of Report
2016-12-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K selectabiosciences8ka_spar.htm 8-K/A 45810
2 EXHIBIT 10.1 exhibit101-sparklicenseagr.htm EX-10.1 698214
3 EXHIBIT 10.2 exhibit102-sparkspaedgarre.htm EX-10.2 235937
4 EXHIBIT 10.3(A) exhibit103a-3rdamendmentto.htm EX-10.3(A) 11615
5 EXHIBIT 10.3(B) exhibit103b-selectamit2xwa.htm EX-10.3(B) 36304
6 EXHIBIT 10.3(C) exhibit103c-sparkxselectam.htm EX-10.3(C) 54223
7 exhibit101selecta_image1.jpg GRAPHIC 3419
8 exhibit101sparklicens_image2.jpg GRAPHIC 81426
9 exhibit103a_mitsignature.jpg GRAPHIC 8754
10 exhibit103a_selectasignature.jpg GRAPHIC 8479
11 g47302g88v35.jpg GRAPHIC 17300
  Complete submission text file 0001453687-16-000020.txt   1247946
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37798 | Film No.: 162051398
SIC: 2834 Pharmaceutical Preparations